Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia

Affiliations

¹ Department of Dermatology, Lahey Hospital & Medical Center, Burlington, Massachusetts.
² Department of Dermatology, Lahey Hospital & Medical Center, Burlington, Massachusetts; Department of Dermatology, Harvard Medical School, Boston, Massachusetts. Electronic address: Maryanne.M.Senna@lahey.org.

Li-Chi Chen et al. J Am Acad Dermatol. 2024 Jun.

. 2024 Jun;90(6):1260-1262.

doi: 10.1016/j.jaad.2024.01.060. Epub 2024 Feb 2.

¹ Department of Dermatology, Lahey Hospital & Medical Center, Burlington, Massachusetts.
² Department of Dermatology, Lahey Hospital & Medical Center, Burlington, Massachusetts; Department of Dermatology, Harvard Medical School, Boston, Massachusetts. Electronic address: Maryanne.M.Senna@lahey.org.

No abstract available

Keywords: JAK inhibitor; Janus kinase inhibitor; alopecia; frontal fibrosing alopecia; lichen planopilaris; scarring alopecia; tofacitinib.

Conflict of interest statement

Conflicts of interest None disclosed.